Давид Серван-Шрейбер - Антирак. Новый образ жизни

107. Khaw, K.-T., et al., “Combined Impact of Health Behaviours and Mortality in Men and Women: The EPIC-Norfolk Prospective Population Study,” PLoS Medicine 5, no. 1 (2008): e12.

108. Hsing, A. W., A. P. Chokkalingam, Y.-T. Gao, et al., “Allium Vegetable and Risk of Prostate Cancer: A Population-Based Study,” Journal of the National Cancer Institute 94, no. 21 (2002): 1648-51; Thomson, M., and M. Ali, “Garlic [Allium sativum]: A Review of Its Potential Use as an Anti-Cancer Agent,” Current Cancer Drug Targets 3, no. 15 (2003): 67-81.

109. Ingram, D., “Diet and Subsequent Survival in Women with Breast Cancer,” British Journal of Cancer 69, no. 3 (1994): 592-95.

110. Chan, J. M., C. N. Holick, M. F. Leitzmann, et al., “Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States),” Cancer Causes & Control 17, no. 2 (2006): 199-208.

111. Canene-Adams, et al., “Combinations of Tomato and Broccoli . . .”

112. Zhang, M., et al., “Dietary Intakes of Mushrooms and Green Tea Combine to Reduce the Risk of Breast Cancer in Chinese Women,” International Journal of Cancer 15 (2009): 1404-8.

113. Maruyama, H., H. Tamauchi, M. Hashimoto, et al., “Antitumor Activity and Immune Response of Mekabu Fucoidan Extracted from Sporophyll of Undaria pinnatifida, ” Vivo 17, no. 3 (2003): 245-49.

114. Shimizu, J., “Proportion of Murine Cytotoxic T Cells Is Increased by High Molecular-Weight Fucoidan Extracted from Okinawa Mozuku ( Cladosiphon okamuranus ),” Journal of Health Sciences 51 (2005): 394-97.

115. Vizzotto, “Inhibition of Invasive Breast Cancer Cells . . .”

116. Taraphdar, A. K., M. Roy, and R. K. Bhattacharya, “Natural Products as Inducers of Apoptosis: Implication for Cancer Therapy and Prevention,” Current Science 80 (2001): 1387-96.

117. Rooprai, H. K., A. Kandanearatchi, S. L. Maidment, et al., “Evaluation of the Effects of Swainsonine, Captopril, Tangeretin and Nobiletin on the Biological Behaviour of Brain Tumour Cells in Vitro,” Neuropathology & Applied Neuro-biology 27, no. 1 (2001): 29-39.

118. Pantuck, A. J., “Phase-II Study of Pomegranate Juice for Men with Prostate Cancer and Increasing PSA,” American Urological Association Annual Meeting, San Antonio, TX, 2005.

119. Manna, S. K., A. Mukhopadhyay, B. B. Aggarwal, “Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-[kappa]B, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation,” Journal of Immunology 164, no. 12 (2000): 6509-19.

120. Kaeberlein, M., T. McDonagh, B. Heltweg, et al., “Substrate-Specific Activation of Sirtuins by Resveratrol,” Journal of Biological Chemistry 280, no. 17 (2005): 17038-45.

121. Lappe, J. M., K. Travers-Gustafson, K. M. Davies, “Vitamin D and Calcium Supplementation Reduces Cancer Risk: Results of a Randomized Trial,” American Journal of Clinical Nutrition 85 (2007): 1586-91.

122. Woo, T. C. S., et al., “Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients with PSA Relapse After Definitive Therapy,” Nutrition & Cancer 51, no. 1 (2005): 32-36.

123. Cannell, J. J. and B. W. Hollis, “Use of Vitamin D in Clinical Practice,” Alternative Medicine Review 13 (2003).

124. Canadian Cancer Society, “La Société Canadienne du Cancer Annonce Ses Recommandations Concernant la Vitamine D,” 2007. (Accessed June 10, 2007, at www.cancer.ca.)

125. Chan, Holick, Leitzman, et al., “Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death.”

126. Gago-Dominguez, M., J. Yuan, C. Sun, et al., “Opposing Effects of Dietary n-3 and n-6 Fatty Acids on Mammary Carcinogenesis: The Singapore Chinese Health Study,” British Journal of Cancer 89, no. 9 (2003): 1686-92.

127. Goodstine, S. L., T. Zheng, T. R. Holford, et al., “Dietary (n-3)/(n-6) Fatty Acid Ratio: Possible Relationship to Premenopausal but Not Postmenopausal Breast Cancer Risk in U.S. Women,” Journal of Nutrition 133, no. 5 (2003): 1409-14.

128. Leitzmann, M., M. Stampfer, D. Michaud, et al., “Dietary Intake of n-3 and n-6 Fatty Acids and the Risk of Prostate Cancer,” American Journal of Clinical Nutrition 80 (2004): 204-16.

129. Hedelin, M., “Association of Frequent Consumption of Fatty Fish with Prostate Cancer Risk Is Modified by COX-2 Polymorphism,” Internation Journal of Cancer 120, no. 2 (2006): 398-405.

130. Norat, T., S. Bingham, P. Ferrari, et al., “Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition,” Journal of the National Cancer Institute 97, no. 12 (2005): 906-16.

131. Terry, P., A. Wolk, H. Vainio, et al., “Fatty Fish Consumption Lowers the Risk of Endometrial Cancer: A Nationwide Case-Control Study in Sweden,” Cancer Epidemiology, Biomarkers & Prevention 11, no. 1 (2002): 143-45.

132. Terry, P., P. Lichtenstein, M. Feychting, et al., “Fatty Fish Consumption and Risk of Prostate Cancer,” Lancet 357, no. 9270 (2001): 1764-66.

133. Hooper, L. T., R. Thompson, R. Harrison, et al., “Risks and Benefits of Omega 3 Fats for Mortality, Cardiovascular Disease, and Cancer: Systematic Review,” British Medical Journal 332 (2006): 752-60.

134. MacLean, C. H., S. J. Newberry, W. A. Mojica, et al., “Effects of Omega-3 Fatty Acids on Cancer Risk: A Systematic Review,” JAMA 295, no. 4 (2006): 403-15.

135. Norat, Bingham, Ferrari, et al., “Meat, Fish, and Colorectal Cancer Risk.”

136. George, S. L., et al., “Impact of Flaxseed Supplementation and Dietary Fat Restriction on Prostate Cancer Proliferation and Other Biomarkers: Results of a Phase II Randomized Controlled Trial (RCT) Using a Presurgical Model,” Journal of Clinical Oncology 63S (2007).

137. Bougnoux, P., et al., “Alpha-Linolenic Acid Content of Adipose Breast Tissue: A Host Determinant of the Risk of Early Metastasis in Breast Cancer,” British Journal of Cancer 70, no. 2 (1994): 330-34.

138. Wollowski, I., G. Rechkemmer, and B. L. Pool-Zobel, “Protective Role of Probiotics and Prebiotics in Colon Cancer,” American Journal of Clinical Nutrition 73, no. 2 (2001): 451S-55.

139. Kim, H. S., et al., “Dietary Supplementation of Probiotic Bacillus Polyfermenti cus, Bispan Strain, Modulates Natural Killer Cell and T Cell Subset Populations and Immunoglobulin G Levels in Human Subjects,” Journal of Medicinal Food 9, no. 3 (2006): 321-27.

140. Rayman, M. P., “The Importance of Selenium to Human Health,” Lancet 356, no. 9225 (2000): 233-41.

141. Kiremidjian-Schumacher, L., M. Roy, H. I. Wishe, “Supplementation with Selenium and Human Immune Cell Functions: II. Effect on Cytotoxic Lymphocytes and Natural Killer Cells,” Biological Trace Element Research 41, no. 1-2 (1994): 115-27.

1. Dolbeault, S., “Quantité de survie versus qualité de vie: quel impact des interventions psychothérapeutiques en oncologie? Le point en 2008,” Revue de presse d’oncologie clinique 17, no. 3 (2008).

2. Lerner, M., Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer (Boston: MIT Press, 1994).

3. Simonton, C. O., S. Matthews-Simonton, and J. Creighton, Guérir Envers et Contre Tout (Paris: Desclée de Brouwer, 1990).

4. Baghurst, K. I., P. A. Baghurst, and S. J. Record, “Public Perceptions of the Role of Dietary and Other Environmental Factors in Cancer Causation or Prevention,” Journal of Epidemiology and Community Health 46 (1992): 120-26.